...
首页> 外文期刊>Endoscopy International Open >Morpho-functional evaluation of small bowel using wireless motility capsule and video capsule endoscopy in patients with known or suspected Crohn’s disease: pilot study
【24h】

Morpho-functional evaluation of small bowel using wireless motility capsule and video capsule endoscopy in patients with known or suspected Crohn’s disease: pilot study

机译:使用无线运动胶囊和视频胶囊内窥镜对已知或疑似克罗恩病患者的小肠进行形态功能评估

获取原文
           

摘要

Background and study aims: SmartPill? (Given Imaging Corp.,Yoqneam,Israel) is an ingestible, non-imaging capsule that records physiological data including contractions and pH throughout the gastrointestinal tract. There are scarce data looking at SmartPill? assessment of patients with known/suspected small-bowel Crohn’s Disease (CD). This pilot study aims to investigate feasibility and safety of SmartPill? to assess gut motility in this group. Patients and methods: Over 1 year, patients with known/suspected CD, referred for small-bowel capsule endoscopy (SBCE), were invited to participate and 12 were recruited (7 female, 5 male, mean age 44.2?±?16.6 years). They underwent hydrogen breath test to exclude small-bowel bacterial overgrowth, patency capsule (Agile?), and provided stool samples for fecal calprotectin (FC). Patients ingested PillCam?SB2 and SmartPill? 4 hours apart. Using unpublished data, 33 healthy controls also were identified for the study. P?
机译:背景和研究目的:SmartPill? (Given Imaging Corp.,以色列约克尼姆)是一种可摄取的非成像胶囊,可记录整个胃肠道的生理数据,包括收缩和pH值。很少有数据在关注SmartPill?对已知/疑似小肠克罗恩病(CD)患者的评估。这项初步研究旨在调查SmartPill?的可行性和安全性。评估该组中的肠蠕动。患者和方法:超过1年,邀请了已知/可疑CD患者接受小肠内镜检查(SBCE),并招募了12名患者(7名女性,5名男性,平均年龄44.2±16.6岁) 。他们进行了氢气呼气试验,以排除小肠细菌的过度生长,通畅胶囊(Agile?),并提供粪便钙卫蛋白(FC)的粪便样本。患者摄入了PillCam?SB2和SmartPill?相隔4个小时。使用未发表的数据,还为该研究确定了33个健康对照。 P≤0.05被认为具有统计学意义。结果:在招募的12位患者中,有10位接受了完整的Smartpill?检查(1胃retention留,1辍学)。 Pillcam?在10内完成(1例辍学,1例胃retention留)。粪便钙卫蛋白的平均值为340±±307.71 mcg / g。与对照组相比,研究组的转运时间更长,肠蠕动指数更低。运动力的差异似乎具有统计学意义(P≤0.05)。 SmartPill的运输时间更长? (无统计学意义)可能是由于胶囊之间的规格不同。局限性包括暂时性Smartpill?信号丢失(5/10个研究)。结论:这是尝试将SBCE和SmartPill结合起来的第一个试点项目?评估小盘CD。 CD活力的数据很少。多峰信息可以提供更清晰的临床图像。尽管担心CD患者的胶囊保留,但SmartPill?如果事先使用通畅胶囊,使用似乎安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号